| [1] |
FUKUNAGA R, GLAZIOU P, HARRIS J B, et al. Epidemiology of tuberculosis and progress toward meeting global targets-worldwide,2019[J]. MMWR Morb Mortal Wkly Rep, 2021, 70(12):427-430.
|
| [2] |
SUDBURY E L, CLIFFORD V, MESSINA N L, et al. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI:a systematic review[J]. J Infect, 2020, 81(6):873-881.
|
| [3] |
SEIFERT M, VARGAS E, RUIZ-VALDEPEÑAS MONTIEL V, et al. Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease[J]. Sci Rep, 2021, 11(1):19193.
DOI
PMID
|
| [4] |
CHAI Q, ZHANG Y, LIU C H. Mycobacterium tuberculosis:an adaptable pathogen associated with multiple human diseases[J]. Front Cell Infect Microbiol, 2018, 8:158.
|
| [5] |
杨丽媛, 戴碗琴, 汪小桐, 等. 外周血中性粒细胞对γ干扰素释放试验结果的影响[J]. 检验医学, 2023, 38(5):484-488.
DOI
|
| [6] |
SINIGAGLIA A, PETA E, RICCETTI S, et al. Tuberculosis-associated microRNAs:from pathogenesis to disease biomarkers[J]. Cells, 2020, 9(10):2160.
|
| [7] |
TU H, YANG S, JIANG T, et al. Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion[J]. Emerg Microbes Infect, 2019, 8(1):448-460.
|
| [8] |
LIU G, WAN Q, LI J, et al. Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2(DRAM2)[J]. Cell Cycle, 2020, 19(22):3182-3194.
|
| [9] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断 [S].北京: 中华人民共和国国家卫生和计划生育委员会, 2018.
|
| [10] |
中华医学会. 临床诊疗指南:结核病分册[M]. 北京: 人民卫生出版社, 2005.
|
| [11] |
季辉, 田爱平, 卢丽艳, 等. 2010—2020年沧州地区肺结核的流行病学特征及危险因素分析[J]. 公共卫生与预防医学, 2021, 32(5):105-108.
|
| [12] |
HUANG L, NAZAROVA E V, RUSSELL D G. Mycobacterium tuberculosis:bacterial fitness within the host macrophage[J]. Microbiol Spectr, 2019, 7(2):10.
|
| [13] |
SHI L, JIANG Q, BUSHKIN Y, et al. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection[J]. mBio, 2019, 10(2):e02550.
|
| [14] |
KALAYCI YÜKSEK F, KIĞ C, ORTAKÖYLÜ G, et al. Association between active pulmonary tuberculosis and circulating microRNAs:a preliminary study from Turkey[J]. Turk J Med Sci, 2021, 51(4):1894-1904.
|
| [15] |
李观强, 张娟娟, 梁娟, 等. miR-20a-5p在肺结核外周血单核细胞中的表达及临床价值[J]. 中国免疫学杂志, 2019, 35(14):1739-1742.
|
| [16] |
TRIBOLET L, KERR E, COWLED C, et al. MicroRNA biomarkers for infectious diseases:from basic research to biosensing[J]. Front Microbiol, 2020, 11:1197.
|
| [17] |
王静娴, 刘雪琴, 仝桃玲, 等. 结核性脑膜炎患儿外周血miR-125b及脑脊液β2微球蛋白表达及临床意义[J]. 中华医院感染学杂志, 2021, 31(9):1431-1435.
|
| [18] |
AHMAD F, RANI A, ALAM A, et al. Macrophage:a cell with many faces and functions in tuberculosis[J]. Front Immunol, 2022, 13:747799.
|
| [19] |
耿晓平, 王鲜茹, 丁雅芳, 等. 活动性肺结核外周血miR-28-3p与miR-93-5p及miR-574-5p表达及临床意义[J]. 中华医院感染学杂志, 2021, 31(11):1617-1622.
|
| [20] |
杨盛娅, 永艳, 崔岩飞, 等. 肺结核患者医院感染后外周血miR-29a-3p水平与巨噬细胞因子的相关性研究[J]. 中华医院感染学杂志, 2018, 28(15):2253-2256.
|